Figures & data
Figure 1 Growth hormone response to two consecutive stress stimuli: (A) exercise followed by exercise (n = 8), (B) insulin-induced hypoglycemia followed by insulin-induced hypoglycemia (n = 9), and (C) hyperthermia followed by hyperthermia (n = 8). The vertical bars (1A) symbolize the work loads during the bicycle ergometer exercise. The horizontal bars (1C) represent the exposure to a sauna. Two way RM ANOVA results are listed in the graphs. NS not significant, *p < 0.05, **p < 0.01 and ***p < 0.001 for timepoint vs. the respective baseline (start of the stimulus) values.
![Figure 1 Growth hormone response to two consecutive stress stimuli: (A) exercise followed by exercise (n = 8), (B) insulin-induced hypoglycemia followed by insulin-induced hypoglycemia (n = 9), and (C) hyperthermia followed by hyperthermia (n = 8). The vertical bars (1A) symbolize the work loads during the bicycle ergometer exercise. The horizontal bars (1C) represent the exposure to a sauna. Two way RM ANOVA results are listed in the graphs. NS not significant, *p < 0.05, **p < 0.01 and ***p < 0.001 for timepoint vs. the respective baseline (start of the stimulus) values.](/cms/asset/32d7b299-9a39-448d-96b0-4fbfdd981218/ists_a_229120_f0001_b.gif)
Table I. Plasma glucose concentrations during two sequential insulin boluses (0.1 IU/kg i.v.) separated by 150 min.
Figure 2 Growth hormone response to two consecutive stimuli: (A) apomorphine administration followed by apomorphine administration (n = 8), (B) insulin-induced hypoglycemia followed by apomorphine administration (n = 9), and (C) apomorphine administration followed by insulin-induced hypoglycemia (n = 8). Two way RM ANOVA results are listed in the graphs. NS not significant, *p < 0.05, **p < 0.01 and ***p < 0.001 for time-point vs. the respective baseline (start of the stimulus) values.
![Figure 2 Growth hormone response to two consecutive stimuli: (A) apomorphine administration followed by apomorphine administration (n = 8), (B) insulin-induced hypoglycemia followed by apomorphine administration (n = 9), and (C) apomorphine administration followed by insulin-induced hypoglycemia (n = 8). Two way RM ANOVA results are listed in the graphs. NS not significant, *p < 0.05, **p < 0.01 and ***p < 0.001 for time-point vs. the respective baseline (start of the stimulus) values.](/cms/asset/c5927236-2485-439d-8de7-5b4d0166a5c5/ists_a_229120_f0002_b.gif)
Figure 3 Growth hormone response to GHRH administration under conditions associated with normal (room temperature, 22°C closed circles) and elevated (increased ambient temperature, 55°C open circles) baseline GH levels (n = 7). The horizontal bar represents the exposure to increased ambient temperature. Two way RM ANOVA results are listed in the graphs. *p < 0.05, **p < 0.01 and ***p < 0.001 for time-point vs. baseline (GHRH administration),+p < 0.05 and ++p < 0.01 room temperature vs. increased ambient temperature.
![Figure 3 Growth hormone response to GHRH administration under conditions associated with normal (room temperature, 22°C closed circles) and elevated (increased ambient temperature, 55°C open circles) baseline GH levels (n = 7). The horizontal bar represents the exposure to increased ambient temperature. Two way RM ANOVA results are listed in the graphs. *p < 0.05, **p < 0.01 and ***p < 0.001 for time-point vs. baseline (GHRH administration),+p < 0.05 and ++p < 0.01 room temperature vs. increased ambient temperature.](/cms/asset/0fb80cee-51ba-43a3-8b3e-4330648eec5d/ists_a_229120_f0003_b.gif)